Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
about
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situRadiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor typeInvestigating intratumour heterogeneity by single-cell sequencingAppraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breastBiomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosisDuctal carcinoma in situ: terminology, classification, and natural historyInferring tumor progression from genomic heterogeneityClonal evolution in cancerPathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situUnderstanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors.A 2D mechanistic model of breast ductal carcinoma in situ (DCIS) morphology and progression.Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity.Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile.Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer.Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patientsClaudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers.Genomic heterogeneity of breast tumor pathogenesismiR-320a is an independent prognostic biomarker for invasive breast cancerA mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma.Tracing the tumor lineage.A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China.Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.Cell-matrix interactions in mammary gland development and breast cancerOf mice and women: A short history of mouse mammary cancer research with an emphasis on the paradigms inspired by the transplantation method.Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathwayPostpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the BreastMicroenvironmental influences that drive progression from benign breast disease to invasive breast cancer.Phenotypic heterogeneity of breast cancer stem cells.Systems biology and genomics of breast cancer.Molecular Markers as Prognostic Factors in DCIS and Small Invasive Breast Cancers.Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.Paired ductal carcinoma in situ and invasive breast cancer lesions in the D-loop of the mitochondrial genome indicate a cancerization field effect.Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epitheliumEmerging understanding of multiscale tumor heterogeneityThe molecular pathology of breast cancer progression.
P2860
Q22000769-4651EFFD-C177-42F9-83B5-73C11674151CQ24620175-56555312-A0E1-4836-B04B-2356D34BF54AQ27015460-7A4DF492-DBDC-4B23-B0E9-D3AA28D6906AQ28083103-88FC7A72-4A7A-4A07-8C5C-B3031CD8CD4EQ28280822-97E323A8-10C2-414D-82C2-9ADD4E0C9F7AQ28296046-F83CC2DF-C08F-4A4B-AF05-7EAACCB8863DQ28749457-8A4878DF-710B-4D7B-A61A-713EA7F512D0Q29547696-895226E7-3844-490B-8C31-091A90A0D041Q29994686-BEC6D7AD-20B8-45CF-B970-C5C1359C3654Q30408300-596818CD-F0DA-4216-BD2D-7DF0DFEFF9FAQ33569159-263D1CFD-7303-410F-9312-FF59873C8100Q33604942-4477DE43-F8A0-4C84-8FAE-BF23FB70E258Q33638070-8D356262-52C4-4632-B929-6E49401DFFA0Q33688929-875C7A9B-34C5-4D6C-8EFD-3E3E091770DCQ33729710-F58C4396-3E0B-4290-984C-A3D34DDF0350Q33767473-7FDA04CE-1B04-4389-8045-1E76566D470DQ33794872-2E6E79B4-CDA2-4C73-AF21-A09707C9F004Q33817330-9704737A-FCDB-4910-85A5-635FE1E6053CQ33825677-544C23BB-BC69-4A43-9CFE-62525DE1D4CCQ33856016-015E7BE4-FC4C-495C-99D7-502BD8CDA7F3Q33860280-09BB9C7B-B1BF-45C1-B672-463FC3C40432Q33967807-299EECB4-C816-4496-A302-04D57D8D0C17Q33997933-2C42F415-74B9-4754-A9CB-834A9FD90FE9Q33998432-2D80F695-9F89-4856-8610-8EFFFE958CC1Q34000512-CC803227-6E9A-402F-AC89-3C4ED0E8B2BFQ34005286-A62F2A0B-DC0C-47AC-9E4C-7FA0F123A133Q34149916-239BB413-37C8-427C-84A5-8E8B763F525DQ34149928-408FFC5E-16A9-43AD-A2C5-66AA52594A97Q34157590-7FFA70ED-635D-44A0-839C-7CEE083BADDFQ34206453-72EE9539-99E5-45F8-8696-E3C83F6ADE8BQ34207931-A2B62365-7413-4B97-8171-FD131D1C42B1Q34444593-8CA29816-A562-48EF-B095-3B5D534902FCQ34521202-ED14A95E-797B-49D9-A20B-83EBB75CA806Q34576377-EC1C3A33-726A-403E-A977-34AE35246219Q34576614-7B4E296A-A3B8-4369-B01E-B31DD04814E6Q34577467-EF4A7002-617C-44CD-895E-F01BEDD47D6BQ34627310-D3E3549F-D77A-4BB2-BC52-9AEDFEA76637Q34686883-E314B5EC-DEB7-4BD2-A1DD-38B0226BB4CDQ34730000-D5E61DAA-10C2-46F2-8F80-6EBD0511E21DQ34752938-CA5E7AB3-DE15-485B-A3C2-3A884864C5E2
P2860
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
@en
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
@nl
type
label
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
@en
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
@nl
prefLabel
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
@en
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
@nl
P2093
P1476
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
@en
P2093
Anna Tsimelzon
D Craig Allred
Dan Medina
Peter O'Connell
Sangjun Lee
Sufeng Mao
Syed K Mohsin
P304
P356
10.1158/1078-0432.CCR-07-1127
P407
P577
2008-01-01T00:00:00Z